{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:11:17Z","timestamp":1778749877471,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003996","name":"Kunming Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008871","name":"Yunnan Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.prp.2026.156496","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:05:46Z","timestamp":1777305946000},"page":"156496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["KLF16 transcriptionally activates HSPB1 to participate in the sorafenib resistance of hepatocellular carcinoma by driving ferroptosis resistance"],"prefix":"10.1016","volume":"283","author":[{"given":"Shujia","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt 3","key":"10.1016\/j.prp.2026.156496_bib1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.semcancer.2021.07.017","article-title":"Epigenetics in hepatocellular carcinoma [J]","volume":"86","author":"Nagaraju","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.prp.2026.156496_bib2","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.7150\/thno.92646","article-title":"GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma [J]","volume":"14","author":"Zhou","year":"2024","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.prp.2026.156496_bib3","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jcmgh.2021.06.005","article-title":"A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib [J]","volume":"12","author":"Pietrobono","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.prp.2026.156496_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.21037\/jgo-22-458","article-title":"Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3\u03b2\/\u03b2-catenin signaling in hepatocellular carcinoma cells [J]","volume":"13","author":"Bian","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156496_bib5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","article-title":"SnapShot: Ferroptosis [J]","volume":"181","author":"Hadian","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-021-01466-9","article-title":"CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma [J]","volume":"21","author":"Chen","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156496_bib7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","article-title":"Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance [J]","volume":"5","author":"Zheng","year":"2024","journal-title":"Nat. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2026.156496_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","article-title":"Targeting Ferroptosis to Iron Out Cancer [J]","volume":"35","author":"Hassannia","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2\/Keap1\/xCT signaling [J]","volume":"26","author":"Fu","year":"2021","journal-title":"Cell. & Mol. Biol. Lett."},{"issue":"12","key":"10.1016\/j.prp.2026.156496_bib10","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis [J]","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib11","first-page":"6","article-title":"Targeting fatty acid synthase modulates sensitivity of hepatocellular carcinoma to sorafenib via ferroptosis [J]","volume":"42","author":"Li","year":"2023","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"6","key":"10.1016\/j.prp.2026.156496_bib12","article-title":"STIM1 promotes acquired resistance to sorafenib by attenuating ferroptosis in hepatocellular carcinoma","volume":"11","author":"Ren","year":"2024","journal-title":"J. ]. Genes & Dis."},{"key":"10.1016\/j.prp.2026.156496_bib13","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma [J]","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist. Update. Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.prp.2026.156496_bib14","article-title":"Kr\u00fcppel-like factors in breast cancer: Function, regulation and clinical relevance","volume":"123","author":"Zhang","year":"2020","journal-title":"J. ]. Biomed. & Pharmacother. = Biomedecine & Pharmacother."},{"issue":"11","key":"10.1016\/j.prp.2026.156496_bib15","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","article-title":"Hepatic Kr\u00fcppel-like Factor 16 (KLF16) targets PPAR\u03b1 to improve steatohepatitis and insulin resistance [J]","volume":"70","author":"Sun","year":"2021","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib16","first-page":"303","article-title":"The KLF16\/MYC feedback loop is a therapeutic target in bladder cancer [J]","volume":"43","author":"Zheng","year":"2024","journal-title":"Journal experimental & clinical cancer research CR"},{"key":"10.1016\/j.prp.2026.156496_bib17","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/CMAR.S334521","article-title":"KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration [J]","volume":"14","author":"Chen","year":"2022","journal-title":"Cancer Manag. Res."},{"issue":"11","key":"10.1016\/j.prp.2026.156496_bib18","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.4251\/wjgo.v14.i11.2157","article-title":"KLF16 promotes pancreatic adenocarcinoma cell proliferation and migration by positively regulating SMAD6 [J]","volume":"14","author":"Mi","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2026.156496_bib19","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1016\/j.ymthe.2022.04.022","article-title":"KLF16 enhances stress tolerance of colorectal carcinomas by modulating nucleolar homeostasis and translational reprogramming [J]","volume":"30","author":"Ma","year":"2022","journal-title":"Molecular therapy journal American Society Gene Therapy"},{"issue":"3","key":"10.1016\/j.prp.2026.156496_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1620\/tjem.2025.J087","article-title":"KLF16-induced Increase of GARS Promotes Glycolysis in Hepatocellular Carcinoma by Stabilizing FOXK1 [J]","volume":"267","author":"Wang","year":"2025","journal-title":"Tohoku J. Exp. Med."},{"issue":"48","key":"10.1016\/j.prp.2026.156496_bib21","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1038\/s41388-025-03625-4","article-title":"Hepatitis B virus X protein promotes the progression and immune escape of hepatocellular carcinoma by activating KLF16-C12orf49-PD-L1 axis [J]","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.prp.2026.156496_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.acthis.2025.152277","article-title":"HSPB1 promotes gastric cancer progression by suppressing PANoptosis [J]","volume":"127","author":"Yang","year":"2025","journal-title":"Acta Histochem."},{"key":"10.1016\/j.prp.2026.156496_bib23","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.2147\/IJGM.S330608","article-title":"Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma [J]","volume":"14","author":"Long","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156496_bib24","first-page":"143","article-title":"Relationship between the expression of phosphorylated heat shock protein beta-1 with lymph node metastases of breast cancer [J]","volume":"15","author":"Kaigorodova","year":"2015","journal-title":"Cancer biomarkers Section A Disease markers"},{"issue":"45","key":"10.1016\/j.prp.2026.156496_bib25","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/onc.2015.32","article-title":"HSPB1 as a novel regulator of ferroptotic cancer cell death [J]","volume":"34","author":"Sun","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41420-023-01660-2","article-title":"Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma [J]","volume":"9","author":"Sun","year":"2023","journal-title":"Cell death Discov."},{"key":"10.1016\/j.prp.2026.156496_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.freeradbiomed.2021.04.024","article-title":"H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis","volume":"169","author":"Asperti","year":"2021","journal-title":"J. ]. Free Radic. Biol. & Med."},{"key":"10.1016\/j.prp.2026.156496_bib28","article-title":"SLC7A11-HSPB1 Axis: A Novel Mechanism for Hepatocellular Carcinoma Progression and Ferroptosis Regulation [J]","author":"An","year":"2025","journal-title":"Biomed. J."},{"issue":"4","key":"10.1016\/j.prp.2026.156496_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.bbrc.2020.06.027","article-title":"KLF16 overexpression deleteriously affects the proliferation and migration of retinoblastoma by transcriptionally repressing BCL2L15 [J]","volume":"529","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2026.156496_bib30","first-page":"3027","article-title":"KLF16 promotes proliferation in gastric cancer cells by regulating p21 and CDK4 [J]","volume":"9","author":"Ma","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"sup1","key":"10.1016\/j.prp.2026.156496_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/21691401.2018.1431654","article-title":"KLF16 suppresses human glioma cell proliferation and tumorigenicity by targeting TFAM [J]","volume":"46","author":"Chen","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib32","first-page":"315","article-title":"Ferroptosis and the tumor microenvironment [J]","volume":"43","author":"Cui","year":"2024","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"4","key":"10.1016\/j.prp.2026.156496_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease [J]","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.prp.2026.156496_bib34","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer [J]","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"12","key":"10.1016\/j.prp.2026.156496_bib35","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.7150\/thno.82132","article-title":"Protein phosphatase 2A-B55\u03b2 mediated mitochondrial p-GPX4 dephosphorylation promoted sorafenib-induced ferroptosis in hepatocellular carcinoma by regulating p53 retrograde signaling [J]","volume":"13","author":"Qian","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156496_bib36","doi-asserted-by":"crossref","DOI":"10.34133\/bmr.0225","article-title":"Hsa_piR_016975 Is a Novel Target of Nanotherapy that Boosts Hepatoma Progression and Sorafenib Resistance by Abating Maspin\/GPX4-Mediated Ferroptosis [J]","volume":"29","author":"Feng","year":"2025","journal-title":"Biomater. Res."},{"key":"10.1016\/j.prp.2026.156496_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105169","article-title":"Apoptosis, autophagy and atherosclerosis: Relationships and the role of Hsp27 [J]","volume":"166","author":"Shan","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156496_bib38","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12885-023-10983-3","article-title":"High HSPB1 expression predicts poor clinical outcomes and correlates with breast cancer metastasis [J]","volume":"23","author":"Huo","year":"2023","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156496_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000431254","article-title":"Hsp27 Acts as a Master Molecular Chaperone and Plays an Essential Role in Hepatocellular Carcinoma Progression [J]","volume":"92","author":"Cheng","year":"2015","journal-title":"Digestion"},{"key":"10.1016\/j.prp.2026.156496_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s11658-019-0143-3","article-title":"MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27 [J]","volume":"24","author":"Yang","year":"2019","journal-title":"Cell. & Mol. Biol. Lett."},{"issue":"7","key":"10.1016\/j.prp.2026.156496_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41419-023-05972-0","article-title":"HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-\u03baB signaling pathway in breast cancer [J]","volume":"14","author":"Liang","year":"2023","journal-title":"Cell death & Dis."},{"issue":"2","key":"10.1016\/j.prp.2026.156496_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5152\/tjg.2024.24101","article-title":"Machine Learning Diagnostic Model for Hepatocellular Carcinoma Based on Liquid-Liquid Phase Separation and Ferroptosis-Related Genes [J]","volume":"36","author":"Chen","year":"2024","journal-title":"Turk. J. Gastroenterol. Off. J. Turk. Soc. Gastroenterol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:28:00Z","timestamp":1778747280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"alternative-id":["S0344033826001494"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156496","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLF16 transcriptionally activates HSPB1 to participate in the sorafenib resistance of hepatocellular carcinoma by driving ferroptosis resistance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156496"}}